A Phase 3 Study of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
Please book an appointment and a member of the staff will guide you providing all the necessary information to participate in this study.